No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Editor's Pick

Why Can Dogs, but Not Humans, Get Vaccinated against Lyme Disease?

by
July 25, 2023
in Editor's Pick
0
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Jeffrey Miron

This article appeared on Substack on July 25, 2023

An interview in the Harvard Gazette with Professor of Medicine Allen Steere explains:

[T]here are currently no vaccines for humans, although there are three for dogs. One had been developed in the late 1990s and pulled off the market in 2002, in part due to a vigorous anti‐​vaccination movement.

Steere goes on to explain that concerns arose about a possible side‐​effect of the vaccine, but those concerns turned out to be invalid. Thus, general vaccine hesitancy, combined with a specific but misplaced fear about the early vaccine have meant no availability for humans so far.

The interview does not address one other factor: the FDA. Absent government restrictions on new medicines, people in earlier decades would have been able to access the initial vaccine, and the manufacturer or independent groups could have collected data on whether the alleged side effect was a genuine problem.

The good news is that a new vaccine is apparently near completion of its phase 3 trials, and an mRNA vaccine is also in the works. Still, many have suffered unnecessarily because of government restrictions on medicine.

Previous Post

The Austrian Theory of the Business Cycle

Next Post

Human Action Conference 2024

Next Post
Human Action Conference 2024

Human Action Conference 2024

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

New working paper: “Shifting Perspectives: An Updated Survey of Environmental and Natural Resource Economists”

May 5, 2025

Last Day to Give in 2023!

December 31, 2023
Bingo, Travel, and Team Building: A Winning Combination for Companies

Bingo, Travel, and Team Building: A Winning Combination for Companies

November 6, 2023
Schedule III Cannabis: Rearranging Prohibition

Schedule III Cannabis: Rearranging Prohibition

0

0

0

0
Schedule III Cannabis: Rearranging Prohibition

Schedule III Cannabis: Rearranging Prohibition

December 12, 2025

“Monkeys Come Full Circle on World Monkey Day: From Electrocution to Release via Rescue and Rehabilitation”

December 12, 2025
Here’s to P.J. O’Rourke!—Now Let’s Get His Papers Archived

Here’s to P.J. O’Rourke!—Now Let’s Get His Papers Archived

December 12, 2025
New Harvard Law Review Article: Plea Bargaining Is Unconstitutional

New Harvard Law Review Article: Plea Bargaining Is Unconstitutional

December 12, 2025

Recent News

Schedule III Cannabis: Rearranging Prohibition

Schedule III Cannabis: Rearranging Prohibition

December 12, 2025

“Monkeys Come Full Circle on World Monkey Day: From Electrocution to Release via Rescue and Rehabilitation”

December 12, 2025
Here’s to P.J. O’Rourke!—Now Let’s Get His Papers Archived

Here’s to P.J. O’Rourke!—Now Let’s Get His Papers Archived

December 12, 2025
New Harvard Law Review Article: Plea Bargaining Is Unconstitutional

New Harvard Law Review Article: Plea Bargaining Is Unconstitutional

December 12, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.